Clinical Trial: A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Migraine
Study Type: INTERVENTIONAL
Official Title: Interventional, Open-label Trial, Investigating the Effectiveness of Eptinezumab in Participants With Migraine and Previous Inadequate Response to CGRP-targeting Therapies
Brief Summary:
The main goal of this trial is to learn whether eptinezumab improves migraine symptoms and quality of life of participants with migraine who did not perceive a sufficient improvement during previous treatment with therapies targeting calcitonin gene-related peptide (CGRP).
Read more